Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3892/mmr.2016.5897

http://scihub22266oqcxt.onion/10.3892/mmr.2016.5897
suck pdf from google scholar
C5355697!5355697 !27840951
unlimited free pdf from europmc27840951
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid27840951
      Mol+Med+Rep 2016 ; 14 (6 ): 5007-5014
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Transcription factor NF?YA promotes a malignant phenotype by upregulating fatty acid synthase expression #MMPMID27840951
  • Guo J ; Kong LM ; Peng AF ; Long XH ; Zhou Y ; Shu Y
  • Mol Med Rep 2016[Dec]; 14 (6 ): 5007-5014 PMID27840951 show ga
  • Recent studies have revealed that increased expression of the alpha subunit of nuclear transcription factor Y (NF?YA) is associated with the malignant phenotype of various tumors. However, whether elevated expression of NF?YA promotes a malignant phenotype in osteosarcoma (OS), and the molecular mechanisms underlying this predicted effect is currently unknown. In the present study, small hairpin RNA (shRNA)?mediated knockdown of endogenous NF?YA significantly inhibited the migration and invasion capabilities of OS cells in vitro, whereas ectopic expression of NF?YA increased the migration and invasion capabilities of these cells. In addition, the induction of upregulated NF?YA expression on the malignant phenotype of OS cells was attenuated by silencing fatty acid synthase (FASN) expression. Furthermore, the expression level of FASN was increased by upregulating NF?YA, while decreased FASN expression was observed following NF?YA silencing in OS cells. The results of the present study suggest that NF?YA may promote a malignant phenotype in OS cells, in part, by activating the FASN signaling pathway, which may represent a promising target for the management of OS.
  • |*Gene Expression Regulation, Neoplastic [MESH]
  • |Biomarkers [MESH]
  • |CCAAT-Binding Factor/*metabolism [MESH]
  • |Cell Line, Tumor [MESH]
  • |Cell Movement/genetics [MESH]
  • |Fatty Acid Synthases/*genetics [MESH]
  • |Gene Expression [MESH]
  • |Humans [MESH]
  • |Immunohistochemistry [MESH]
  • |Neoplasms/*genetics/*metabolism [MESH]
  • |Phenotype [MESH]
  • |RNA, Small Interfering/genetics [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box